Overview
Kate Milner practices practicing medicine in Melbourne, Australia.
Her clinical expertise encompasses Prader-Willi Syndrome, Streptococcal Group B Infection, and Premature Infant.
She is actively involved in clinical research, co-authoring 23 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kate M. Milner
Is Kate M. Milner a top-rated expert for Prader-Willi Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Kate M. Milner is classified as an Experienced expert for Prader-Willi Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kate M. Milner participate in research or clinical trials?
Yes. Kate M. Milner has published 23 articles and abstracts on conditions like Prader-Willi Syndrome. You can view a list of Kate M. Milner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Prader-Willi SyndromeMs. Milner isExperienced. Learn about Prader-Willi Syndrome.
- Premature InfantMs. Milner isExperienced. Learn about Premature Infant.
- Streptococcal Group B InfectionMs. Milner isExperienced. Learn about Streptococcal Group B Infection.